Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CEP72 Protein (Myc-DYKDDDDK Tag)

CEP72 Origin: Human Host: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
Catalog No. ABIN2713921
  • Target See all CEP72 Proteins
    CEP72 (Centrosomal Protein 72kDa (CEP72))
    Protein Type
    Recombinant
    Origin
    • 1
    • 1
    Human
    Source
    • 2
    HEK-293 Cells
    Purification tag / Conjugate
    This CEP72 protein is labelled with Myc-DYKDDDDK Tag.
    Application
    Antibody Production (AbP), Standard (STD)
    Characteristics
    • Recombinant human CEP72 protein expressed in HEK293 cells.
    • Produced with end-sequenced ORF clone
    Purity
    > 80 % as determined by SDS-PAGE and Coomassie blue staining
    Top Product
    Discover our top product CEP72 Protein
  • Application Notes
    Recombinant human proteins can be used for:
    Native antigens for optimized antibody production
    Positive controls in ELISA and other antibody assays
    Comment

    The tag is located at the C-terminal.

    Restrictions
    For Research Use only
  • Concentration
    50 μg/mL
    Buffer
    25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
    Storage
    -80 °C
    Storage Comment
    Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
  • Target
    CEP72 (Centrosomal Protein 72kDa (CEP72))
    Alternative Name
    Cep72 (CEP72 Products)
    Synonyms
    RGD1566336 Protein, 2610029E11Rik Protein, 4933440J22Rik Protein, centrosomal protein 72 Protein, CEP72 Protein, Cep72 Protein, cep72 Protein
    Background
    The product of this gene is a member of the leucine-rich-repeat (LRR) superfamily of proteins. The protein is localized to the centrosome, a non-membraneous organelle that functions as the major microtubule-organizing center in animal cells.
    Molecular Weight
    71.5 kDa
    NCBI Accession
    NP_060610
    Pathways
    M Phase
You are here:
Support